NO20051077L - Vannloselige polymeralkanaler - Google Patents

Vannloselige polymeralkanaler

Info

Publication number
NO20051077L
NO20051077L NO20051077A NO20051077A NO20051077L NO 20051077 L NO20051077 L NO 20051077L NO 20051077 A NO20051077 A NO 20051077A NO 20051077 A NO20051077 A NO 20051077A NO 20051077 L NO20051077 L NO 20051077L
Authority
NO
Norway
Prior art keywords
water
soluble polymer
polymer channels
channels
polymeric
Prior art date
Application number
NO20051077A
Other languages
English (en)
Norwegian (no)
Inventor
Antoni Kozlowski
Original Assignee
Nektar Therapeutics Al Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nektar Therapeutics Al Corp filed Critical Nektar Therapeutics Al Corp
Publication of NO20051077L publication Critical patent/NO20051077L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/30Compounds having groups
    • C07C43/315Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00Compounds having —CHO groups
    • C07C47/02Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen
    • C07C47/198Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/26Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
    • C08G65/2603Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing oxygen
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/34Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
    • C08G65/48Polymers modified by chemical after-treatment
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00Applications
    • C08L2203/02Applications for biomedical use

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Polyethers (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
NO20051077A 2002-09-09 2005-02-28 Vannloselige polymeralkanaler NO20051077L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40925102P 2002-09-09 2002-09-09
US45658003P 2003-03-19 2003-03-19
PCT/US2003/028221 WO2004022630A2 (fr) 2002-09-09 2003-09-09 Alcanales polymeres solubles dans l'eau

Publications (1)

Publication Number Publication Date
NO20051077L true NO20051077L (no) 2005-04-08

Family

ID=31981629

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20051078A NO20051078L (no) 2002-09-09 2005-02-28 Vannloselige polymeralkanaler
NO20051077A NO20051077L (no) 2002-09-09 2005-02-28 Vannloselige polymeralkanaler

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20051078A NO20051078L (no) 2002-09-09 2005-02-28 Vannloselige polymeralkanaler

Country Status (22)

Country Link
US (5) US7157546B2 (fr)
EP (1) EP1546235B1 (fr)
JP (2) JP4764630B2 (fr)
KR (2) KR20050093856A (fr)
AP (2) AP2005003249A0 (fr)
AU (1) AU2003270454B2 (fr)
BR (1) BR0314172A (fr)
CA (1) CA2498167C (fr)
EA (1) EA200500475A1 (fr)
EC (1) ECSP055654A (fr)
ES (1) ES2897470T3 (fr)
GE (1) GEP20074193B (fr)
HR (2) HRP20050319A2 (fr)
IS (1) IS7789A (fr)
MA (1) MA27401A1 (fr)
MX (1) MXPA05002620A (fr)
NO (2) NO20051078L (fr)
NZ (2) NZ540490A (fr)
PL (1) PL375883A1 (fr)
RS (2) RS20050202A (fr)
UA (1) UA80838C2 (fr)
WO (1) WO2004022630A2 (fr)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7053150B2 (en) * 2000-12-18 2006-05-30 Nektar Therapeutics Al, Corporation Segmented polymers and their conjugates
WO2003061577A2 (fr) 2002-01-18 2003-07-31 Biogen Idec Ma Inc. Composes polymeres de polyalkylene et utilisations de ceux-ci
DE10209822A1 (de) * 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
DE10209821A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
ES2897470T3 (es) * 2002-09-09 2022-03-01 Nektar Therapeutics Alcanales poliméricos solubles en agua
WO2004024776A1 (fr) 2002-09-11 2004-03-25 Fresenius Kabi Deutschland Gmbh Procede de production de derives d'amidon hydroxyalkyle
EA008866B1 (ru) * 2002-12-26 2007-08-31 Маунтин Вью Фамэсьютикэлс, Инк. ПОЛИМЕРНЫЙ КОНЪЮГАТ МОДИФИКАЦИЙ ИНТЕРФЕРОНА-β, ФАРМАЦЕВТИЧЕСКИЕ ПРОДУКТЫ НА ЕГО ОСНОВЕ И СПОСОБ ИХ ПОЛУЧЕНИЯ
TWI364295B (en) * 2002-12-26 2012-05-21 Mountain View Pharmaceuticals Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity
EP2572732A1 (fr) * 2003-02-26 2013-03-27 Nektar Therapeutics Conjugués de groupes polymère-facteur VIII
US7947261B2 (en) * 2003-05-23 2011-05-24 Nektar Therapeutics Conjugates formed from polymer derivatives having particular atom arrangements
GB0314472D0 (en) 2003-06-20 2003-07-23 Warwick Effect Polymers Ltd Polymer
WO2005014655A2 (fr) * 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugues d'amidon d'hydroxyalkyle et de proteine
US20080274948A1 (en) * 2003-08-08 2008-11-06 Fresenius Kabi Deutschland Gmbh Conjugates of Hydroxyalkyl Starch and G-Csf
EP2336192A1 (fr) * 2004-03-11 2011-06-22 Fresenius Kabi Deutschland GmbH Conjugues d'amidon hydroxyalkyle et d'une protein, preparer par amination réductive
CN102302787A (zh) * 2004-03-11 2012-01-04 费森尤斯卡比德国有限公司 羟烷基淀粉和蛋白质的接合物
AU2005222641B2 (en) 2004-03-15 2011-04-07 Nektar Therapeutics Polymer-based compositions and conjugates of HIV entry inhibitors
WO2005094898A2 (fr) * 2004-03-23 2005-10-13 Amgen Inc. Compositions de protéines chimiquement modifiées et procédés
KR101330338B1 (ko) * 2004-07-16 2013-11-15 넥타르 테라퓨틱스 Gm―csf 부분 및 중합체의 콘쥬게이트
KR20070042567A (ko) * 2004-08-31 2007-04-23 파마시아 앤드 업존 캄파니 엘엘씨 글리세롤 분지쇄 폴리에틸렌 글리콜 인간 성장 호르몬공액체, 이의 제조 방법 및 이의 사용 방법
CA2584510C (fr) * 2004-10-25 2013-05-28 Intezyne Technologies, Incorporated Poly(ethyleneglycol) heterobifonctionnel et utilisations associees
AU2006222187A1 (en) * 2005-03-11 2006-09-14 Fresenius Kabi Deutschland Gmbh Production of bioactive glycoproteins from inactive starting material by conjugation with hydroxyalkylstarch
WO2007010552A2 (fr) * 2005-03-17 2007-01-25 Serum Institute Of India Limited Conjugue d'erythropoietine peg n-terminal
WO2006102659A2 (fr) * 2005-03-23 2006-09-28 Nektar Therapeutics Al, Corporation Conjugues d'un fragment de hgh et d'un polymere
EP1762250A1 (fr) * 2005-09-12 2007-03-14 Fresenius Kabi Deutschland GmbH Conjugués d' amidon hydroxyalkyle et une substance active obtenue par ligation chimique via thiazolidine
WO2007075534A2 (fr) 2005-12-16 2007-07-05 Nektar Therapeutics Al, Corporation Conjugues polymeres de glp-1
EP1834963A1 (fr) * 2006-03-13 2007-09-19 Siegfried Ltd. Conjugues de proteines et de dipolymeres et leurs procedes de preparation
CA2861601A1 (fr) * 2006-04-27 2007-11-08 Intezyne Technologies, Inc. Poly(ethylene glycol) contenant des endogroupes chimiquement disparates
CL2008002399A1 (es) * 2007-08-16 2009-01-02 Pharmaessentia Corp Conjugado sustancialmente puro que posee una porcion polimerica, una porcion proteica (interferon alfa 2b) y un ligante alifatico de 1 a 10 atomos de carbono, util en el tratamiento de las hepatitis b o c.
EP2070950A1 (fr) 2007-12-14 2009-06-17 Fresenius Kabi Deutschland GmbH Dérivés hydroxyalkylés de l'amidon et leur procédé de préparation
EP2070951A1 (fr) 2007-12-14 2009-06-17 Fresenius Kabi Deutschland GmbH Procédé de production d'un dérivé hydroxyalkyle de l'amidon avec deux liens
EP2254601B1 (fr) 2008-02-08 2019-05-29 Nektar Therapeutics Conjugués d'oligomère et de cannabinoïde
KR100967833B1 (ko) * 2008-05-20 2010-07-05 아이디비켐(주) 고순도의 폴리에틸렌글리콜 알데하이드 유도체의 제조방법
EA020347B1 (ru) * 2008-07-31 2014-10-30 Фармаиссэншиа Корп. Пептид-полимерные конъюгаты
US8492503B2 (en) 2008-09-11 2013-07-23 Nektar Therapeutics Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method
WO2010033220A2 (fr) * 2008-09-19 2010-03-25 Nektar Therapeutics Peptides thérapeutiques modifiés, procédés pour les préparer et les utiliser
WO2010033207A1 (fr) 2008-09-19 2010-03-25 Nektar Therapeutics Conjugués polymères de peptides thérapeutiques
GB0823309D0 (en) * 2008-12-19 2009-01-28 Univ Bath Functionalising reagents and their uses
JP5602850B2 (ja) 2009-07-14 2014-10-08 ザ スクリプス リサーチ インスティテュート 間葉幹細胞分化
NZ603399A (en) 2010-05-17 2014-09-26 Cebix Inc Pegylated c-peptide
RU2447083C1 (ru) * 2010-07-20 2012-04-10 Закрытое Акционерное Общество "Биокад" НОВЫЙ ФУНКЦИОНАЛЬНО АКТИВНЫЙ ВЫСОКООЧИЩЕННЫЙ СТАБИЛЬНЫЙ КОНЪЮГАТ ИНТЕРФЕРОНА α С ПОЛИЭТИЛЕНГЛИКОЛЕМ, ПРЕДСТАВЛЕННЫЙ ОДНИМ ПОЗИЦИОННЫМ ИЗОМЕРОМ ПЭГ-NαH-ИФН, С УМЕНЬШЕННОЙ ИММУНОГЕННОСТЬЮ, С ПРОЛОНГИРОВАННЫМ БИОЛОГИЧЕСКИМ ДЕЙСТВИЕМ, ПРИГОДНЫЙ ДЛЯ МЕДИЦИНСКОГО ПРИМЕНЕНИЯ, И ИММУНОБИОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ
WO2012054822A1 (fr) 2010-10-22 2012-04-26 Nektar Therapeutics Conjugués polymère-glp 1 pharmacologiquement actifs
WO2012065086A1 (fr) * 2010-11-12 2012-05-18 Nektar Therapeutics Conjugués d'une fraction il-2 et d'un polymère
EP2540325B1 (fr) * 2011-06-27 2016-08-10 Greatbatch Ltd. Revêtement antimicrobien à base de peptides
EP2592103A1 (fr) * 2011-11-08 2013-05-15 Adriacell S.p.A. Dérivés d'aldéhyde de polymère
JP5999659B2 (ja) * 2011-12-14 2016-09-28 国立大学法人 筑波大学 新規分岐ポリエチレングリコール及びその用途
JO3564B1 (ar) 2013-03-08 2020-07-05 Novartis Ag ببتيدات وتركيبات لعلاج ضرر المفاصل
MA38369B1 (fr) 2013-03-08 2018-10-31 Novartis Ag Peptides et compositions pour le traitement d'une lesion de l'articulation
JP6106104B2 (ja) 2014-01-16 2017-03-29 信越化学工業株式会社 末端にアミノ基を有する狭分散ポリアルキレングリコール誘導体の製造方法
JP6106103B2 (ja) * 2014-01-16 2017-03-29 信越化学工業株式会社 末端にアミノ基を有する狭分散ポリアルキレングリコール誘導体の製造方法、並びにこれに用いる新規なアセタール基含有アルコール化合物及びそのアルカリ金属塩
GB201419108D0 (en) 2014-10-27 2014-12-10 Glythera Ltd Materials and methods relating to linkers for use in antibody drug conjugates
MY191506A (en) 2014-11-06 2022-06-28 Pharmaessentia Corp Dosage regimen for pegylated interferon
AR116566A1 (es) 2018-10-03 2021-05-19 Novartis Ag Administración sostenida de polipéptidos similares a la angiopoyetina 3

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002531A (en) * 1976-01-22 1977-01-11 Pierce Chemical Company Modifying enzymes with polyethylene glycol and product produced thereby
JPS5695142A (en) * 1979-12-28 1981-08-01 T Hasegawa Co Ltd Preparation of aliphatic aldehyde
JPS63152393A (ja) * 1986-07-03 1988-06-24 Takeda Chem Ind Ltd グリコシル誘導体
US5037969A (en) 1986-07-03 1991-08-06 Takeda Chemical Industries, Ltd. Glycosyl derivatives and use thereof
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
AU4660789A (en) 1988-11-23 1990-06-12 Genentech Inc. Polypeptide derivatives
US5252714A (en) * 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
JPH06233816A (ja) 1993-02-12 1994-08-23 Toyobo Co Ltd 血液浄化吸着材
US5840900A (en) * 1993-10-20 1998-11-24 Enzon, Inc. High molecular weight polymer-based prodrugs
US5919455A (en) 1993-10-27 1999-07-06 Enzon, Inc. Non-antigenic branched polymer conjugates
US5627662A (en) * 1994-04-28 1997-05-06 Xerox Corporation Digital imaging system using two-dimensional input sensor array and output light valve
FR2724459B1 (fr) 1994-09-14 1997-05-09 Univ Compiegne Tech Electrophorese capillaire d'affinite, matrice d'affinite pour la mise en oeuvre de cette electrophorese et son procede de fabrication
US5824784A (en) * 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
US5672662A (en) * 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
US5736543A (en) * 1996-04-03 1998-04-07 The Regents Of The University Of California Benzoxazines for enhancing synaptic response
US5990237A (en) * 1997-05-21 1999-11-23 Shearwater Polymers, Inc. Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines
JPH11322916A (ja) 1998-05-11 1999-11-26 Kazunori Kataoka ビオチン残基を片末端に有するヘテロテレケリツクポリマー
US6420555B1 (en) * 1998-06-16 2002-07-16 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Imidazolyl derivatives
US6465694B1 (en) * 1998-10-26 2002-10-15 University Of Utah Research Foundation Method for preparation of polyethylene glycol aldehyde derivatives
AU2346900A (en) 1998-11-30 2000-06-19 Eli Lilly And Company Erythropoietic compounds
JP2000303090A (ja) * 1999-04-20 2000-10-31 T Hasegawa Co Ltd 香料組成物
KR100653153B1 (ko) * 1999-12-22 2006-12-01 넥타르 테라퓨틱스 에이엘, 코포레이션 수용성 중합체의 입체장애 유도체
TW593427B (en) 2000-12-18 2004-06-21 Nektar Therapeutics Al Corp Synthesis of high molecular weight non-peptidic polymer derivatives
MXPA04004336A (es) * 2001-11-07 2005-05-16 Nektar Therapeutics Al Corp Polimeros ramificados y sus conjugados.
HUP0500997A2 (en) 2001-11-20 2007-11-28 Pharmacia Corp Chemically-modified human growth hormone conjugates
US20030171285A1 (en) * 2001-11-20 2003-09-11 Finn Rory F. Chemically-modified human growth hormone conjugates
EP1507755A4 (fr) * 2001-12-11 2006-05-17 Sun Bio Inc Nouveaux aldehydes de polyethyleneglycol monofonctionnels
US6956135B2 (en) * 2001-12-11 2005-10-18 Sun Bio, Inc. Monofunctional polyethylene glycol aldehydes
US6916962B2 (en) * 2001-12-11 2005-07-12 Sun Bio, Inc. Monofunctional polyethylene glycol aldehydes
WO2003061577A2 (fr) 2002-01-18 2003-07-31 Biogen Idec Ma Inc. Composes polymeres de polyalkylene et utilisations de ceux-ci
WO2003091987A1 (fr) * 2002-04-26 2003-11-06 Idemitsu Kosan Co., Ltd. Dispositif et element structurel d'absorption des bruits et procede de fabrication associe
CN1671769B (zh) * 2002-07-24 2010-05-12 弗·哈夫曼-拉罗切有限公司 聚乙二醇醛衍生物
ES2897470T3 (es) * 2002-09-09 2022-03-01 Nektar Therapeutics Alcanales poliméricos solubles en agua
PA8588901A1 (es) * 2002-11-20 2005-02-04 Pharmacia Corp Conjugados de hormona de crecimiento humana pegilados n-terminales y proceso para su preparacion
US20040142870A1 (en) * 2002-11-20 2004-07-22 Finn Rory F. N-terminally monopegylated human growth hormone conjugates, process for their preparation, and methods of use thereof
US6961962B1 (en) * 2004-09-09 2005-11-08 Morning Pride Manufacturing, L.L.C. Combined closure and liner zippers employing common zipper tapes and protective garment employing said combined zippers
JP5084245B2 (ja) 2006-06-07 2012-11-28 関西ペイント株式会社 澱粉系塗料組成物

Also Published As

Publication number Publication date
KR20050057281A (ko) 2005-06-16
JP4764630B2 (ja) 2011-09-07
US20120065429A1 (en) 2012-03-15
US8076412B2 (en) 2011-12-13
UA80838C2 (en) 2007-11-12
ECSP055654A (es) 2005-05-30
US7157546B2 (en) 2007-01-02
US20110034737A1 (en) 2011-02-10
US8853325B2 (en) 2014-10-07
PL375883A1 (en) 2005-12-12
US20090234070A1 (en) 2009-09-17
AU2003270454A1 (en) 2004-03-29
KR20050093856A (ko) 2005-09-23
US7511094B2 (en) 2009-03-31
JP2005538224A (ja) 2005-12-15
AP2005003249A0 (en) 2005-03-31
AU2003270454B2 (en) 2010-05-20
WO2004022630A2 (fr) 2004-03-18
EP1546235A2 (fr) 2005-06-29
HRP20050320A2 (en) 2006-12-31
AP2005003246A0 (en) 2005-03-31
JP2005350470A (ja) 2005-12-22
US20060194940A1 (en) 2006-08-31
BR0314172A (pt) 2005-07-26
NO20051078L (no) 2005-04-08
EP1546235B1 (fr) 2021-10-20
US20040116649A1 (en) 2004-06-17
ES2897470T3 (es) 2022-03-01
RS20050202A (en) 2007-08-03
HRP20050319A2 (en) 2006-12-31
KR100974843B1 (ko) 2010-08-11
NZ540490A (en) 2007-10-26
NZ538624A (en) 2007-01-26
CA2498167C (fr) 2012-03-20
CA2498167A1 (fr) 2004-03-18
MA27401A1 (fr) 2005-06-01
GEP20074193B (en) 2007-09-10
WO2004022630A3 (fr) 2004-04-15
IS7789A (is) 2005-04-08
US7838595B2 (en) 2010-11-23
RS20050203A (en) 2007-08-03
MXPA05002620A (es) 2005-05-05
EA200500475A1 (ru) 2005-10-27

Similar Documents

Publication Publication Date Title
NO20051077L (no) Vannloselige polymeralkanaler
ATE491475T1 (de) Konjugate enthaltend gm-csf und ein polymer
NO20071504L (no) Pyrimidinderivanter.
DE60333937D1 (de) Substituierte quinazolinone verbindungen
HK1103552A1 (en) Dibenzosilol polymers, their preparation and uses
WO2006104957A3 (fr) Antioxydants macromoleculaires alkyles et polymeres et procedes pour les produire et les utiliser
MX2009011198A (es) Peliculas que comprenden una pluralidad de polimeros.
DK1206467T3 (da) N-heterocykliske derivater som NOS-inhibitorer
WO2005066151A3 (fr) Inhibiteurs d'histone desacetylase
NO20082793L (no) Nye tiofenderivater
TW200512212A (en) Alkylenedioxythiophenes and poly(alkylenedioxythiophenes) containing mesogenic groups
NO20064934L (no) Fremgangsmate for fremstilling av et fast, farmasoytisk preparat
EP1709699B8 (fr) Polymeres conjugues, leur representation et leur utilisation
WO2001082909A3 (fr) Derives de 2-acyl-indole et leur utilisation comme agents antitumoraux
PT1419163E (pt) Imidazopiridinas triciclicas
CY1105275T1 (el) Ενωσεις υποκατεστημενης γ-λακτονης ως ανταγωνισται - νμda
NO20053588D0 (no) Acylaminotiazol-derivater, fremstilling og anvendelse derav som beta-amyloidpeptid-produksjonsinhibitorer.
DK1495104T3 (da) Anvendelse af polymerer, der indholder termoplastiske polymerer som filtreringshjælpe- og/eller stabiliseringsmiddel
BRPI0415390A (pt) compostos de pirazinona substituìda para o tratamento da inflamação
WO2006048152A3 (fr) Nouveaux derives de dicarboxamide
BRPI0415285A (pt) derivados de aminoalcanol
EP4011827A4 (fr) Composé diphosphite d'hydrogène poly/mono-hypophosphite, préparation et utilisation associées
NO20074167L (no) Peptidiske forbindelser
ECSP034532A (es) Derivados del 1-aminobutan-3-ol sustituido
IL188927A0 (en) Aryloxy quinolines and uses thereof as 5-ht6 modulators

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application